69238-2088 : Bexarotene 10 mg/g Topical Gel


NDC69238-2088
Labeler: Amneal Pharmaceuticals Ny LLC
Product Type: Human Prescription Drug
Drug Name:  Bexarotene
Dosage Form: Topical Gel
Application #: ANDA215398
Rev. Date: 


NDC Package Codes:

  • 69238-2088-6: 1 TUBE IN 1 CARTON (69238‑2088‑6) > 60 G IN 1 TUBE

Active Ingredients:

  • Bexarotene

Dosage Strength:

  • 10 mg/g

Pharmaceutical Classes:

  • Retinoid [EPC]
  • Retinoids [CS]

Related Products:

Based on records with the same trade name.
  • 69238-1250 Bexarotene 75 mg Oral Capsule by Amneal Pharmaceuticals LLC
  • 0054-0399 Bexarotene 75 mg Oral Capsule, Liquid Filled by Hikma Pharmaceuticals USA Inc.
  • 0378-6955 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Pharmaceuticals Inc.
  • 0591-2832 Bexarotene 75 mg Oral Capsule, Liquid Filled by Actavis Pharma, Inc.
  • 0832-0285 Bexarotene 75 mg Oral Capsule by Upsher-smith Laboratories, Inc.
  • 42291-072 Bexarotene 75 mg Oral Capsule by Avkare
  • 42292-007 Bexarotene 75 mg Oral Capsule, Liquid Filled by Mylan Institutional Inc.
  • 43975-315 Bexarotene 75 mg Oral Capsule, Liquid Filled by Amerigen Pharmaceuticals Inc.
  • 68682-002 Bexarotene 1 g/100g Topical Gel by Oceanside Pharmaceuticals
  • 68682-003 Bexarotene 75 mg Oral Capsule, Liquid Filled by Oceanside Pharmaceuticals

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 69238-2088 QR Code

< Prev: 69238-2081Next: 69238-2090 >

Related Discussions:

Bexarotene for Alzheimer's
Hi - has anyone else heard about the research being done on Bexarotene as a viable Alzheimer's treatment? Apparently... 4 replies




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.